ZA981897B - Formualtions for immunological potentiation of vaccines - Google Patents

Formualtions for immunological potentiation of vaccines

Info

Publication number
ZA981897B
ZA981897B ZA981897A ZA981897A ZA981897B ZA 981897 B ZA981897 B ZA 981897B ZA 981897 A ZA981897 A ZA 981897A ZA 981897 A ZA981897 A ZA 981897A ZA 981897 B ZA981897 B ZA 981897B
Authority
ZA
South Africa
Prior art keywords
formualtions
vaccines
potentiation
immunological
immunological potentiation
Prior art date
Application number
ZA981897A
Other languages
English (en)
Inventor
Julio Cesar Aguilar Rubido
Verena Lucila Muzio Gonzalez
Maria De Jesus Leal Angulo
Gerardo Enrique Guillen Nieto
Eduardo Penton Arias
Gloria Veliz Rios
Dagmara Pichardo Diaz
Antonieta Herrera Buch
Enrique Iglesias Perez
Luis Javier Cruz Ricondo
Tania Carmenate Portilla
Cirse Mesa Pardillo
Maydel Hechavarria Gay
Maylin Diaz Martinez
Juan Joel Madrazo Pinol
Original Assignee
Cigb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cigb filed Critical Cigb
Publication of ZA981897B publication Critical patent/ZA981897B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
ZA981897A 1997-03-06 1998-03-05 Formualtions for immunological potentiation of vaccines ZA981897B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997027A CU22629A1 (es) 1997-03-06 1997-03-06 Formulaciones inmunopotenciadoras para uso vacunal

Publications (1)

Publication Number Publication Date
ZA981897B true ZA981897B (en) 1998-09-07

Family

ID=5459228

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA981897A ZA981897B (en) 1997-03-06 1998-03-05 Formualtions for immunological potentiation of vaccines

Country Status (15)

Country Link
US (1) US6355414B1 (fr)
EP (1) EP0971737B1 (fr)
CN (1) CN1161154C (fr)
AR (1) AR009866A1 (fr)
AT (1) ATE295182T1 (fr)
AU (1) AU6607798A (fr)
BR (1) BR9808832A (fr)
CA (1) CA2283344A1 (fr)
CU (1) CU22629A1 (fr)
DE (1) DE69830156T2 (fr)
ES (1) ES2241122T3 (fr)
HK (1) HK1026626A1 (fr)
MY (1) MY132817A (fr)
WO (1) WO1998039032A1 (fr)
ZA (1) ZA981897B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011845B2 (en) * 2000-05-09 2006-03-14 Mcp Hahnemann University β-glucans encapsulated in liposomes
CU23011A1 (es) * 2000-11-03 2004-12-17 Ct Ingenieria Genetica Biotech Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones
CU23031A1 (es) * 2002-01-24 2005-02-23 Ct Ingenieria Genetica Biotech Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
US20060105063A1 (en) * 2004-11-18 2006-05-18 Kent Hann Synergic combination of compositions containing aloe vera isolates and their therapeutic application
AP2695A (en) 2005-04-25 2013-07-16 Cadila Pharmaceuticals Ltd Vaccine adjuvants
US20080220028A1 (en) 2006-12-15 2008-09-11 National Research Council Of Canada Archaeal polar lipid aggregates for administration to animals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
EP0418626B1 (fr) * 1989-09-08 1993-12-29 Takeda Chemical Industries, Ltd. Protéines fusionnées, et leur production
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
UA40596C2 (uk) * 1992-05-23 2001-08-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини та спосіб її одержання
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
JPH08183742A (ja) * 1994-12-28 1996-07-16 Dai Ichi Seiyaku Co Ltd 経鼻ワクチンリポソーム
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤

Also Published As

Publication number Publication date
EP0971737A1 (fr) 2000-01-19
HK1026626A1 (en) 2000-12-22
AU6607798A (en) 1998-09-22
EP0971737B1 (fr) 2005-05-11
US6355414B1 (en) 2002-03-12
DE69830156T2 (de) 2006-01-26
WO1998039032A1 (fr) 1998-09-11
AR009866A1 (es) 2000-05-03
CN1252002A (zh) 2000-05-03
CU22629A1 (es) 2000-12-22
CA2283344A1 (fr) 1998-09-11
MY132817A (en) 2007-10-31
ES2241122T3 (es) 2005-10-16
CN1161154C (zh) 2004-08-11
ATE295182T1 (de) 2005-05-15
DE69830156D1 (de) 2005-06-16
BR9808832A (pt) 2000-07-04

Similar Documents

Publication Publication Date Title
GB9712347D0 (en) Vaccine
GB9718901D0 (en) Vaccine
PL341761A1 (en) Vaccine
GB9711990D0 (en) Vaccine
GB9726555D0 (en) Vaccine
GB9720585D0 (en) Vaccine
SI0870508T1 (en) Influenza vaccine
GB9713149D0 (en) Pharmaceutical formulations
GB9503863D0 (en) Vaccine compositions
ZA982073B (en) Pharmaceutical preparation
ZA981897B (en) Formualtions for immunological potentiation of vaccines
HUP0003159A3 (en) The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions
EP1210364A4 (fr) Antigenes de vaccin provenant de moraxella
IL109519A0 (en) Vaccines for oral immunization against infecting agents
GB9718616D0 (en) Oral vaccine
GB9702990D0 (en) Virus vaccine
HUT72403A (en) Babesia vaccine
GR3032256T3 (en) Babesia vaccine
GB9814470D0 (en) Parasite vaccine
TJ307B (en) A method for the preparation of a anti - theileriosis vaccine
IL125952A0 (en) Process for preparation of sulfonylurea salts
LT97134A (en) Method for the preparation of zeolites
GB9720982D0 (en) Vaccine
GB9718902D0 (en) Vaccine
GB9717423D0 (en) Vaccine